80 related articles for article (PubMed ID: 17729334)
21. Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis.
Rheinheimer S; Christopoulos P; Erdmann S; Saupe J; Golpon H; Vogel-Claussen J; Dinkel J; Thomas M; Heussel CP; Kauczor HU; Heussel G
BMC Med Imaging; 2022 Dec; 22(1):215. PubMed ID: 36471318
[TBL] [Abstract][Full Text] [Related]
22. Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction.
Jones MA; Islam W; Faiz R; Chen X; Zheng B
Front Oncol; 2022; 12():980793. PubMed ID: 36119479
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Cone-Beam Breast Computed Tomography for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Prospective Study.
Chen S; Li S; Zhou C; He N; Chen J; Pei S; Li J; Wu Y; Cai P
J Oncol; 2022; 2022():9321763. PubMed ID: 35528237
[TBL] [Abstract][Full Text] [Related]
24. The Radiological Response Rate Pattern Is Associated With Recurrence Free Survival in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Ahn J; Park WC; Yoon CI; Paik PS; Cho MK; Yoo TK
J Breast Cancer; 2022 Apr; 25(2):106-116. PubMed ID: 35506579
[TBL] [Abstract][Full Text] [Related]
25. A Complex Radiomic Signature in Luminal Breast Cancer from a Weighted Statistical Framework: A Pilot Study.
Castaldo R; Garbino N; Cavaliere C; Incoronato M; Basso L; Cuocolo R; Pace L; Salvatore M; Franzese M; Nicolai E
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204589
[TBL] [Abstract][Full Text] [Related]
26. Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response.
Stevens W; Farrow IM; Georgiou L; Hanby AM; Perren TJ; Windel LM; Wilson DJ; Sharma N; Dodwell D; Hughes TA; Dall BJ; Buckley DL
Br J Radiol; 2021 Jul; 94(1123):20201396. PubMed ID: 34106751
[TBL] [Abstract][Full Text] [Related]
27. Hyperpolarized
Woitek R; McLean MA; Gill AB; Grist JT; Provenzano E; Patterson AJ; Ursprung S; Torheim T; Zaccagna F; Locke M; Laurent MC; Hilborne S; Frary A; Beer L; Rundo L; Patterson I; Slough R; Kane J; Biggs H; Harrison E; Lanz T; Basu B; Baird R; Sala E; Graves MJ; Gilbert FJ; Abraham JE; Caldas C; Brindle KM; Gallagher FA
Radiol Imaging Cancer; 2020 Jul; 2(4):e200017. PubMed ID: 32803167
[TBL] [Abstract][Full Text] [Related]
28. The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis.
Cheng Q; Huang J; Liang J; Ma M; Ye K; Shi C; Luo L
Front Oncol; 2020; 10():93. PubMed ID: 32117747
[No Abstract] [Full Text] [Related]
29. Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients.
Zhang Y; Li J; Fan Y; Li X; Qiu J; Zhu M; Li H
Medicine (Baltimore); 2019 Oct; 98(40):e17481. PubMed ID: 31577783
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.
Vivoda Tomšič M; Bisdas S; Kovač V; Serša I; Šurlan Popovič K
Cancer Imaging; 2019 Feb; 19(1):10. PubMed ID: 30813957
[TBL] [Abstract][Full Text] [Related]
31. DCE-MRI and parametric imaging in monitoring response to neoadjuvant chemotherapy in breast carcinoma: a preliminary report.
Sharma A; Sharma S; Sood S; Seam RK; Sharma M; Fotedar V
Pol J Radiol; 2018; 83():e220-e228. PubMed ID: 30627239
[TBL] [Abstract][Full Text] [Related]
32. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
33. Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results.
Kang H; Hainline A; Arlinghaus LR; Elderidge S; Li X; Abramson VG; Chakravarthy AB; Abramson RG; Bingham B; Fakhoury K; Yankeelov TE
J Med Imaging (Bellingham); 2018 Jan; 5(1):011015. PubMed ID: 29322067
[TBL] [Abstract][Full Text] [Related]
34. Assessing treatment response in triple-negative breast cancer from quantitative image analysis in perfusion magnetic resonance imaging.
Banerjee I; Malladi S; Lee D; Depeursinge A; Telli M; Lipson J; Golden D; Rubin DL
J Med Imaging (Bellingham); 2018 Jan; 5(1):011008. PubMed ID: 29134191
[TBL] [Abstract][Full Text] [Related]
35. US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.
Kim MJ; Su MY; Yu HJ; Chen JH; Kim EK; Moon HJ; Choi JS
BMC Cancer; 2016 Feb; 16():50. PubMed ID: 26833069
[TBL] [Abstract][Full Text] [Related]
36. The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy.
Lim I; Noh WC; Park J; Park JA; Kim HA; Kim EK; Park KW; Lee SS; You EY; Kim KM; Byun BH; Kim BI; Choi CW; Lim SM
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1852-60. PubMed ID: 24927797
[TBL] [Abstract][Full Text] [Related]
37. MRI and ¹⁸F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?
Evangelista L; Ruggieri D; Pescarini L; Saladini G
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1511-4. PubMed ID: 24898847
[No Abstract] [Full Text] [Related]
38. Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
Li X; Kang H; Arlinghaus LR; Abramson RG; Chakravarthy AB; Abramson VG; Farley J; Sanders M; Yankeelov TE
Transl Oncol; 2014 Feb; 7(1):14-22. PubMed ID: 24772203
[TBL] [Abstract][Full Text] [Related]
39. The effects of applying breast compression in dynamic contrast material-enhanced MR imaging.
El Khouli RH; Macura KJ; Kamel IR; Bluemke DA; Jacobs MA
Radiology; 2014 Jul; 272(1):79-90. PubMed ID: 24620911
[TBL] [Abstract][Full Text] [Related]
40. [Therapy monitoring of neoadjuvant therapy with MRI. RECIST and functional imaging].
Grandl S; Ingrisch M; Hellerhoff K
Radiologe; 2014 Mar; 54(3):233-40. PubMed ID: 24585048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
